Superiority of Fondaparinux Over Enoxaparin in Preventing Venous Thromboembolism in Major Orthopedic Surgery Using Different Efficacy End Points
- 1 August 2004
- Vol. 126 (2) , 501-508
- https://doi.org/10.1378/chest.126.2.501
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic SurgeryA Meta-analysis of 4 Randomized Double-blind StudiesArchives of internal medicine (1960), 2002
- Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparisonThe Lancet, 2002
- Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trialThe Lancet, 2002
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture SurgeryNew England Journal of Medicine, 2001
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee SurgeryNew England Journal of Medicine, 2001
- Cannabis Arteritis RevisitedAngiology, 2001
- Prevention of Venous ThromboembolismChest, 2001
- Noninvasive Diagnosis of Deep Venous ThrombosisAnnals of Internal Medicine, 1998
- Value of the Ventilation/Perfusion Scan in Acute Pulmonary EmbolismJAMA, 1990
- Roentgen Diagnosis of Venous Thrombosis in the LegArchives of Surgery, 1972